Others titles

  • Transparency Reports and Reporting of Physician Ownership or Investment Interests
  • Research Payment Data
  • Research Payment Analytics
  • Covered Recipients Analytics (Physicians, Teaching Hospitals, Non Covered Recipients)
  • Manufacturer’s or GPO’s Research Payments Analytics
  • Disputed / Undisputed Records Analytics
  • Research subjects Analytics (Drugs or Devices)

Keywords

  • Open Payments
  • Affordable Care Act
  • Sunshine Act
  • Transparency programs
  • Research Payments Detail

CMS Research Payment Details for Covered Recipients 2013

Dataset for reported Research Payments for the 2013 program year. Research payment records provide the total value of a payment or other transfer of value made for research purposes to a particular recipient for a particular date.
This dataset has been refreshed to include the most recent attested-to data for program year 2013.

Log in to download
Complexity

Get The Data

For getting access to data download links please read and accept the end-user license agreement.
Your Data License
  • Research
    Non-Commercial, Share-Alike, Attribution Free Forever
  • Commercial
    Commercial Use, Remix & Adapt, White Label Log in to download

John Snow Labs Standard End User License Agreement

Last updated:January 20, 2021

This Data Library End User License Agreement (“EULA”) applies to academic researchers, educators, and students using any product of John Snow Labs in John Snow Labs’ Data Library as defined below (hereinafter referred to “you”). This EULA is between you and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).

By downloading and/or using (as applicable) Data Library of John Snow Labs (as defined below), you automatically agree to be bound by, and use it in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.

PLEASE READ THIS EULA CAREFULLY BEFORE DOWNLOADING OR USING DATA LIBRARY.

We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of Data Library after such changes have been published to our EULA will constitute your acceptance of such revised EULA.

Definitions

“Data Library” means a data library provided by John Snow Labs and located at https://www.johnsnowlabs.com/marketplace/;

“Website” means https://www.johnsnowlabs.com being owned and operated by John Snow Labs.

Important Notice

By downloading and using any product from the Data Library, you acknowledge that the use of Data Library can be subject to the restrictions and controls imposed by United States export regulations.

You represent and warrant that you do not intend to use Data Library for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.

Eligibility

Our Data Library can be used by an individual.

In the event you have entered into a separate written agreement with John Snow Labs regarding Data Library that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all

License Granted

Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, revocable, license to download, access to, modify, and use of, Data Library worldwide (subject to applicable export laws) during the term of this EULA (as described below) under the following conditions:

  • The license can be used solely for research, private study and personal use of Data Library for unlimited period, or unless terminated under this EULA.were made;
  • This license is personal to you and is limited by all terms and conditions set forth in this EULA;
  • The license is granted as a non-commercial, attribution, share-alike and no-derivate-work license as more detailed below;
  • Under the attribution license, you must give the appropriate name of the creator and a copyright notice of John Snow Labs, provide link to this license and indicate if changes
  • Under the share-alike license, you can distribute modified works only under a license identical to this EULA;
  • Under the no-derivate-work license, you can perform only verbatim copies of Data Library, not derivate works or remixes based on it;
  • If the license is used for academic research purpose, the publication shall be made under the open-access, open-source and open-data license.

You can download any dataset from the Data Library from the Website.

Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Data Library, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Data Library is protected by applicable intellectual property laws, including United States copyright law and international treaties.

John Snow Labs is entitled to revoke the license granted at any time at its sole discretion.

License Restrictions

You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of Data Library. You are responsible for end users’ use of your content and Data Library. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and Data Library by such end user.

License Restrictions

You will access or use our Data Library solely via John Snow Labs’ Data Library.

Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:

  1. you cannot reproduce, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of Data Library or its technological features or measures;
  2. you cannot rent, lease, sell, resell, loan, distribute, or sublicense access to any of Data Library;
  3. you cannot circumvent or disable any security or technological features or measures of Data Library;
  4. you cannot use our intellectual property rights without our express prior written authorization or in violation of this EULA;
  5. you cannot use Data Library with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of Data Library;
  6. you cannot copy, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on Data Library (collectively, “Content”) or compile or collect any Content as part of a database or other work;
  7. you cannot use any automated tool (e.g., robots, spiders) to access or use Data Library, or to store, copy, modify, distribute, or resell any Content;
  8. you cannot circumvent or disable any rights management, usage rules, or other security features of Data Library;
  9. you cannot use Data Library in a manner that overburdens, or that threatens the integrity, performance, or availability of, Data Library; or
  10. you cannot remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of Data Library or any Content.

If you breach any of this EULA, the above license will terminate automatically.

Fees and Taxes

This license is for non-commercial use. If you wish to use our Data Library for commercial use, please contact us at support@JohnSnowLabs.com.

Support and Updates

Under this EULA, support services are excluded.

From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.

Term and Termination

This EULA will become effective as of the date of your order of Data Library and shall be in effect until terminated.

John Snow Labs may suspend or terminate your right to use Data Library, if you or your end user’s use of Data Library:

  1. is in breach of this EULA;
  2. poses a security risk to Data Library;
  3. could adversely impact our systems, Data Library or other customers;
  4. could subject us, our affiliates, or any third party to liability; or
  5. could be fraudulent.

We may also suspend or terminate your right to use Data Library, if you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.

You will cease use of Data Library during any period of suspension, or upon termination of this EULA.

All provisions which by their nature are intended to survive termination shall survive termination of this EULA.

Access to Data Library

We do not provide you with the equipment to access Data Library. You are responsible for all fees charged by third parties related to your access and use of Data Library (e.g., charges by Internet service providers).

You are responsible for monitoring your use of Data Library, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of Data Library for auditing purposes.

You also certify that you are legally permitted to use Data Library, and take full responsibility for the selection and use of Data Library. This EULA is void where prohibited by law, and the right to use Data Library is revoked in such jurisdictions. John Snow Labs makes no claim that Data Library may be lawfully used outside of the United States. If you use Data Library from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.

Privacy Policy

We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.

Links and Third Party Content

Data Library may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using Data Library (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.

We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using Data Library, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.

Proprietary Rights

John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.

Data Library is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to Data Library or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of Data Library or any Content.

Trademarks

“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on Data Library are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of Data Library, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in Data Library are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.

Disclaimer of Warranties

YOUR USE OF DATA LIBRARY IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.

Limitation of Liability

WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.

Indemnity

To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of Data Library; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.

Legal Notices

Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of Data Library will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.

Notifications

We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Data Library. We will not send you newsletters unless you expressly consented to such notifications.

Contacting Us

If you have any questions or concerns about Data Library or this EULA, you may contact us by email at support@JohnSnowLabs.com.

Description

Open Payments, which is managed by the Centers for Medicare & Medicaid Services (CMS), is a national disclosure program created by the Affordable Care Act (ACA) that promotes transparency and accountability by helping consumers understand the financial relationships between pharmaceutical and medical device industries and physicians and teaching hospitals. These financial relationships may include consulting fees, research grants, travel reimbursements, and payments made from the industry to medical practitioners.

Each record includes identifying information for the applicable manufacturer or applicable Group Purchasing Organization (GPO) who made the payment, and identifying information for the recipient. Information is also provided for up to five principal investigators associated with the payment.

Each record also lists, if applicable, up to five covered drugs or biologicals, or up to five covered devices or medical supplies, that were part of the research payment or other transfers of value.

Each record now includes a Change Type indicator field. In General Payment, Research Payment, and Ownership/Investment records, the Change Type value indicates if the record is new (NEW), if the record is being published for the first time despite having been submitted during an earlier submission period due to the record not being eligible for publication until the current publication (ADD), if the record has been previously published but modified since its last publication (CHANGED), or if the record is being republished without change in the current publication (UNCHANGED). A record whose only change since the last publication is a change to its dispute status is categorized as a changed record.

About this Dataset

Data Info

Date Created

2014-06

Last Modified

2020-01-03

Version

2020-01-03

Update Frequency

Annual

Temporal Coverage

2013-01 to 2013-12

Spatial Coverage

United States

Source

John Snow Labs; Centers of Medicare and Medicaid Services (CMS);

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

Open Payments, Affordable Care Act, Sunshine Act, Transparency programs, Research Payments Detail

Other Titles

Transparency Reports and Reporting of Physician Ownership or Investment Interests, Research Payment Data, Research Payment Analytics, Covered Recipients Analytics (Physicians, Teaching Hospitals, Non Covered Recipients), Manufacturer’s or GPO’s Research Payments Analytics, Disputed / Undisputed Records Analytics, Research subjects Analytics (Drugs or Devices)

Data Fields

Name Description Type Constraints
Change_TypeIndicator showing if the payment record is New, Added, Modified, or Unchanged in the current publication compared to the previous publication.stringrequired : 1enum : Array ( [0] => NEW [1] => ADD [2] => CHANGED [3] => UNCHANGED ) maxLength : 20
Covered_Recipient_TypeIndicator showing if recipient of the payment or other transfer of value is a physician covered recipient, teaching hospital covered recipient, non-covered recipient entity or non-covered recipient individualstringrequired : 1maxLength : 50
Noncovered_Recipient_Entity_NameThe name of the non-covered recipient entity receiving the payment or other transfer of valuestringmaxLength : 50
Teaching_Hospital_CCNA unique identifying number (CMS Certification Number) of the Teaching Hospital receiving the payment or other transfer of valuestringmaxLength : 6
Teaching_Hospital_IDSystem-generated unique identifier of the teaching hospital receiving the payment or other transfer of valueintegerlevel : Nominal
Teaching_Hospital_NameThe name of the teaching hospital receiving the payment or other transfer of value – the name displayed is as listed in the CMS teaching hospital liststringmaxLength : 100
Physician_Profile_IDSystem-generated unique identifier for physician profile receiving the payment or other transfer of valueintegerlevel : Nominal
Physician_First_NameFirst name of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entitystringmaxLength : 20
Physician_Middle_NameMiddle name of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entitystringmaxLength : 20
Physician_Last_NameLast name of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entitystringmaxLength : 35
Physician_Name_SuffixName suffix of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entitystringmaxLength : 5
Recipient_Primary_Business_Street_Address_Line1The first line of the primary business street address of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of valuestringmaxLength : 55
Recipient_Primary_Business_Street_Address_Line2The second line of the primary business street address of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of valuestringmaxLength : 55
Recipient_CityThe primary practice/business address city of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of valuestringmaxLength : 40
Recipient_StateThe state or territory abbreviation of the primary business address of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary business address is in the United StatesstringmaxLength : 2
Recipient_Zip_CodeThe 9-digit zip code for the primary business location of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 10
Recipient_CountryThe primary practice/business address country of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 100
Recipient_ProvinceThe primary practice/business province name of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicablestringmaxLength : 20
Recipient_Postal_CodeThe international postal code for the primary business location of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary business address is outside the United StatesstringmaxLength : 20
Physician_Primary_TypePrimary type name of medicine practiced by the physician (covered recipient)stringmaxLength : 50
Physician_SpecialtyPhysician's single specialty chosen from the standardized "provider taxonomy" code liststringmaxLength : 300
Physician_License_State_Code1The state license number of the covered recipient physician, which is a 2-letter state abbreviation.stringmaxLength : 2
Physician_License_State_Code2The state license number of the covered recipient physician, which is a 2-letter state abbreviation.stringmaxLength : 2
Physician_License_State_Code3The state license number of the covered recipient physician, which is a 2-letter state abbreviation.stringmaxLength : 2
Physician_License_State_Code4The state license number of the covered recipient physician, which is a 2-letter state abbreviation.stringmaxLength : 2
Physician_License_State_Code5The state license number of the covered recipient physician, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_1_Profile_IDAn identifier for principal investigator profile after validationintegerlevel : Nominal
Principal_Investigator_1_First_NameFirst name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_1_Middle_NameMiddle name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_1_Last_NameLast name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 35
Principal_Investigator_1_Name_SuffixName suffix of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 5
Principal_Investigator_1_Business_Street_Address_Line1The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_1_Business_Street_Address_Line2The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_1_CityThe primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 40
Principal_Investigator_1_StateThe primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 2
Principal_Investigator_1_Zip_CodeThe 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 10
Principal_Investigator_1_CountryThe primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 100
Principal_Investigator_1_ProvinceThe primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicablestringmaxLength : 20
Principal_Investigator_1_Postal_CodeThe international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United StatesstringmaxLength : 20
Principal_Investigator_1_Primary_TypePrimary type name of medicine practiced by the principal investigatorstringmaxLength : 100
Principal_Investigator_1_SpecialtyPrincipal investigator's single specialty chosen from the standardized "provider taxonomy" code liststringmaxLength : 300
Principal_Investigator_1_License_State_Code1The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_1_License_State_Code2The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_1_License_State_Code3The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_1_License_State_Code4The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_1_License_State_Code5The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_2_Profile_IDAn identifier for principal investigator profile after validationintegerlevel : Nominal
Principal_Investigator_2_First_NameFirst name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_2_Middle_NameMiddle name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_2_Last_NameLast name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 35
Principal_Investigator_2_Name_SuffixName suffix of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 5
Principal_Investigator_2_Business_Street_Address_Line1The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_2_Business_Street_Address_Line2The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_2_CityThe primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 40
Principal_Investigator_2_StateThe primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 2
Principal_Investigator_2_Zip_CodeThe 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 10
Principal_Investigator_2_CountryThe primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 100
Principal_Investigator_2_ProvinceThe primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicablestringmaxLength : 20
Principal_Investigator_2_Postal_CodeThe international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United StatesstringmaxLength : 20
Principal_Investigator_2_Primary_TypePrimary type name of medicine practiced by the principal investigatorstringmaxLength : 100
Principal_Investigator_2_SpecialtyPrincipal investigator's single specialty chosen from the standardized "provider taxonomy" code liststringmaxLength : 300
Principal_Investigator_2_License_State_Code1The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_2_License_State_Code2The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_2_License_State_Code3The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_2_License_State_Code4The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_2_License_State_Code5The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_3_Profile_IDAn identifier for principal investigator profile after validationintegerlevel : Nominal
Principal_Investigator_3_First_NameFirst name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_3_Middle_NameMiddle name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_3_Last_NameLast name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 35
Principal_Investigator_3_Name_SuffixName suffix of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 5
Principal_Investigator_3_Business_Street_Address_Line1The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_3_Business_Street_Address_Line2The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_3_CityThe primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 40
Principal_Investigator_3_StateThe primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 2
Principal_Investigator_3_Zip_CodeThe 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 10
Principal_Investigator_3_CountryThe primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 100
Principal_Investigator_3_ProvinceThe primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicablestringmaxLength : 20
Principal_Investigator_3_Postal_CodeThe international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United StatesstringmaxLength : 20
Principal_Investigator_3_Primary_TypePrimary type name of medicine practiced by the principal investigatorstringmaxLength : 100
Principal_Investigator_3_SpecialtyPrincipal investigator's single specialty chosen from the standardized "provider taxonomy" code liststringmaxLength : 300
Principal_Investigator_3_License_State_Code1The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_3_License_State_Code2The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_3_License_State_Code3The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_3_License_State_Code4The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_3_License_State_Code5The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_4_Profile_IDAn identifier for principal investigator profile after validationintegerlevel : Nominal
Principal_Investigator_4_First_NameFirst name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_4_Middle_NameMiddle name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_4_Last_NameLast name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 35
Principal_Investigator_4_Name_SuffixName suffix of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 5
Principal_Investigator_4_Business_Street_Address_Line1The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_4_Business_Street_Address_Line2The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_4_CityThe primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 40
Principal_Investigator_4_StateThe primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 2
Principal_Investigator_4_Zip_CodeThe 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 10
Principal_Investigator_4_CountryThe primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 100
Principal_Investigator_4_ProvinceThe primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicablestringmaxLength : 20
Principal_Investigator_4_Postal_CodeThe international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United StatesstringmaxLength : 20
Principal_Investigator_4_Primary_TypePrimary type name of medicine practiced by the principal investigatorstringmaxLength : 100
Principal_Investigator_4_SpecialtyPrincipal investigator's single specialty chosen from the standardized "provider taxonomy" code liststringmaxLength : 300
Principal_Investigator_4_License_State_Code1The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_4_License_State_Code2The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_4_License_State_Code3The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_4_License_State_Code4The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_4_License_State_Code5The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_5_Profile_IDAn identifier for principal investigator profile after validationintegerlevel : Nominal
Principal_Investigator_5_First_NameFirst name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_5_Middle_NameMiddle name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 20
Principal_Investigator_5_Last_NameLast name of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 35
Principal_Investigator_5_Name_SuffixName suffix of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 5
Principal_Investigator_5_Business_Street_Address_Line1The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_5_Business_Street_Address_Line2The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of valuestringmaxLength : 55
Principal_Investigator_5_CityThe primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 40
Principal_Investigator_5_StateThe primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 2
Principal_Investigator_5_Zip_CodeThe 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 10
Principal_Investigator_5_CountryThe primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United StatesstringmaxLength : 100
Principal_Investigator_5_ProvinceThe primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicablestringmaxLength : 20
Principal_Investigator_5_Postal_CodeThe international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United StatesstringmaxLength : 20
Principal_Investigator_5_Primary_TypePrimary type name of medicine practiced by the principal investigatorstringmaxLength : 100
Principal_Investigator_5_SpecialtyPrincipal investigator's single specialty chosen from the standardized "provider taxonomy" code liststringmaxLength : 300
Principal_Investigator_5_License_State_Code1The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_5_License_State_Code2The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_5_License_State_Code3The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_5_License_State_Code4The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Principal_Investigator_5_License_State_Code5The state license number of the principal investigator, which is a 2-letter state abbreviation.stringmaxLength : 2
Submitting_Applicable_Manufacturer_or_Applicable_GPO_NameTextual proper name of either the submitting applicable manufacturer or applicable GPOstringrequired : 1maxLength : 100
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_IDSystem-generated unique identifier of the applicable manufacturer or applicable GPO making the payment or other transfer of valueintegerlevel : Nominalrequired : 1
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_NameTextual proper name of the applicable manufacturer or applicable GPO making the payment or other transfer of valuestringrequired : 1maxLength : 100
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_StateState name of the submitting applicable manufacturer or applicable GPOstringmaxLength : 2
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_CountryCountry name of the applicable manufacturer or applicable GPOstringrequired : 1maxLength : 100
Product_IndicatorIndicator allows the applicable manufacturer or applicable GPO to select whether the payment or other transfer of value is associated withstringrequired : 1maxLength : 50
Name_of_Associated_Covered_Drug_or_Biological1The marketed name of the drug or biological associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Drug_or_Biological2The marketed name of the drug or biological associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Drug_or_Biological3The marketed name of the drug or biological associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Drug_or_Biological4The marketed name of the drug or biological associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Drug_or_Biological5The marketed name of the drug or biological associated with this payment or other transfer of valuestringmaxLength : 100
NDC_of_Associated_Covered_Drug_or_Biological1The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable)stringmaxLength : 12
NDC_of_Associated_Covered_Drug_or_Biological2The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable)stringmaxLength : 12
NDC_of_Associated_Covered_Drug_or_Biological3The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable)stringmaxLength : 12
NDC_of_Associated_Covered_Drug_or_Biological4The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable)stringmaxLength : 12
NDC_of_Associated_Covered_Drug_or_Biological5The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable)stringmaxLength : 12
Name_of_Associated_Covered_Device_or_Medical_Supply1The marketed name of the device or medical supply associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Device_or_Medical_Supply2The marketed name of the device or medical supply associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Device_or_Medical_Supply3The marketed name of the device or medical supply associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Device_or_Medical_Supply4The marketed name of the device or medical supply associated with this payment or other transfer of valuestringmaxLength : 100
Name_of_Associated_Covered_Device_or_Medical_Supply5The marketed name of the device or medical supply associated with this payment or other transfer of valuestringmaxLength : 100
Total_Amount_of_Payment_USDollarsUS dollar amount of payment or other transfer of value to recipientnumberlevel : Ratiorequired : 1
Date_of_PaymentIf a singular payment, then this is the actual date the payment was issued; if a series of payments or an aggregated set of payments, this is the date of the first payment to the covered recipient in this program yeardaterequired : 1
Form_of_Payment_or_Transfer_of_ValueThe method of payment used to pay the covered recipient or to make the transfer of valuestringrequired : 1maxLength : 100
Expenditure_Category1Contextual category for this research payment or other transfer of valuestringmaxLength : 50
Expenditure_Category2Contextual category for this research payment or other transfer of valuestringmaxLength : 50
Expenditure_Category3Contextual category for this research payment or other transfer of valuestringmaxLength : 50
Expenditure_Category4Contextual category for this research payment or other transfer of valuestringmaxLength : 50
Expenditure_Category5Contextual category for this research payment or other transfer of valuestringmaxLength : 50
Expenditure_Category6Contextual category for this research payment or other transfer of valuestringmaxLength : 50
Is_Preclinical_Research_IndicatorIndicator showing if payment or other transfer of value is related to research, which is pre-clinicalboolean-
Is_Delay_in_Publication_IndicatorIndicator showing if an applicable manufacturer or applicable GPO is requesting a delay in publication of a payment or other transfer of valueboolean-
Name_of_StudyThe textual name of the study for which the covered recipient is receiving this payment or other transfer of valuestringmaxLength : 500
Is_Dispute_Status_for_PublicationIndicates whether the payment or other transfer of value is disputed by the covered recipient or notboolean-
Record_IDSystem-assigned identifier to the general transaction at the time of submissionintegerlevel : Nominalrequired : 1
Program_YearThe year in which the payment occurreddaterequired : 1
Payment_Publication_DateThe predefined date when the payment or other transfer of value is scheduled to be publisheddaterequired : 1
ClinicalTrials_Gov_IdentifierIdentifier assigned if research study is registered on clinicaltrials.govstringmaxLength : 11
Research_Information_LinkOptional link to information relevant to the research study for which this payment or other transfer of value is being reportedstringmaxLength : 2083
Context_of_ResearchTextual description of research context or research objectivesstringmaxLength : 500

Data Preview

Change TypeCovered Recipient TypeNoncovered Recipient Entity NameTeaching Hospital CCNTeaching Hospital IDTeaching Hospital NamePhysician Profile IDPhysician First NamePhysician Middle NamePhysician Last NamePhysician Name SuffixRecipient Primary Business Street Address Line1Recipient Primary Business Street Address Line2Recipient CityRecipient StateRecipient Zip CodeRecipient CountryRecipient ProvinceRecipient Postal CodePhysician Primary TypePhysician SpecialtyPhysician License State Code1Physician License State Code2Physician License State Code3Physician License State Code4Physician License State Code5Principal Investigator 1 Profile IDPrincipal Investigator 1 First NamePrincipal Investigator 1 Middle NamePrincipal Investigator 1 Last NamePrincipal Investigator 1 Name SuffixPrincipal Investigator 1 Business Street Address Line1Principal Investigator 1 Business Street Address Line2Principal Investigator 1 CityPrincipal Investigator 1 StatePrincipal Investigator 1 Zip CodePrincipal Investigator 1 CountryPrincipal Investigator 1 ProvincePrincipal Investigator 1 Postal CodePrincipal Investigator 1 Primary TypePrincipal Investigator 1 SpecialtyPrincipal Investigator 1 License State Code1Principal Investigator 1 License State Code2Principal Investigator 1 License State Code3Principal Investigator 1 License State Code4Principal Investigator 1 License State Code5Principal Investigator 2 Profile IDPrincipal Investigator 2 First NamePrincipal Investigator 2 Middle NamePrincipal Investigator 2 Last NamePrincipal Investigator 2 Name SuffixPrincipal Investigator 2 Business Street Address Line1Principal Investigator 2 Business Street Address Line2Principal Investigator 2 CityPrincipal Investigator 2 StatePrincipal Investigator 2 Zip CodePrincipal Investigator 2 CountryPrincipal Investigator 2 ProvincePrincipal Investigator 2 Postal CodePrincipal Investigator 2 Primary TypePrincipal Investigator 2 SpecialtyPrincipal Investigator 2 License State Code1Principal Investigator 2 License State Code2Principal Investigator 2 License State Code3Principal Investigator 2 License State Code4Principal Investigator 2 License State Code5Principal Investigator 3 Profile IDPrincipal Investigator 3 First NamePrincipal Investigator 3 Middle NamePrincipal Investigator 3 Last NamePrincipal Investigator 3 Name SuffixPrincipal Investigator 3 Business Street Address Line1Principal Investigator 3 Business Street Address Line2Principal Investigator 3 CityPrincipal Investigator 3 StatePrincipal Investigator 3 Zip CodePrincipal Investigator 3 CountryPrincipal Investigator 3 ProvincePrincipal Investigator 3 Postal CodePrincipal Investigator 3 Primary TypePrincipal Investigator 3 SpecialtyPrincipal Investigator 3 License State Code1Principal Investigator 3 License State Code2Principal Investigator 3 License State Code3Principal Investigator 3 License State Code4Principal Investigator 3 License State Code5Principal Investigator 4 Profile IDPrincipal Investigator 4 First NamePrincipal Investigator 4 Middle NamePrincipal Investigator 4 Last NamePrincipal Investigator 4 Name SuffixPrincipal Investigator 4 Business Street Address Line1Principal Investigator 4 Business Street Address Line2Principal Investigator 4 CityPrincipal Investigator 4 StatePrincipal Investigator 4 Zip CodePrincipal Investigator 4 CountryPrincipal Investigator 4 ProvincePrincipal Investigator 4 Postal CodePrincipal Investigator 4 Primary TypePrincipal Investigator 4 SpecialtyPrincipal Investigator 4 License State Code1Principal Investigator 4 License State Code2Principal Investigator 4 License State Code3Principal Investigator 4 License State Code4Principal Investigator 4 License State Code5Principal Investigator 5 Profile IDPrincipal Investigator 5 First NamePrincipal Investigator 5 Middle NamePrincipal Investigator 5 Last NamePrincipal Investigator 5 Name SuffixPrincipal Investigator 5 Business Street Address Line1Principal Investigator 5 Business Street Address Line2Principal Investigator 5 CityPrincipal Investigator 5 StatePrincipal Investigator 5 Zip CodePrincipal Investigator 5 CountryPrincipal Investigator 5 ProvincePrincipal Investigator 5 Postal CodePrincipal Investigator 5 Primary TypePrincipal Investigator 5 SpecialtyPrincipal Investigator 5 License State Code1Principal Investigator 5 License State Code2Principal Investigator 5 License State Code3Principal Investigator 5 License State Code4Principal Investigator 5 License State Code5Submitting Applicable Manufacturer or Applicable GPO NameApplicable Manufacturer or Applicable GPO Making Payment IDApplicable Manufacturer or Applicable GPO Making Payment NameApplicable Manufacturer or Applicable GPO Making Payment StateApplicable Manufacturer or Applicable GPO Making Payment CountryProduct IndicatorName of Associated Covered Drug or Biological1Name of Associated Covered Drug or Biological2Name of Associated Covered Drug or Biological3Name of Associated Covered Drug or Biological4Name of Associated Covered Drug or Biological5NDC of Associated Covered Drug or Biological1NDC of Associated Covered Drug or Biological2NDC of Associated Covered Drug or Biological3NDC of Associated Covered Drug or Biological4NDC of Associated Covered Drug or Biological5Name of Associated Covered Device or Medical Supply1Name of Associated Covered Device or Medical Supply2Name of Associated Covered Device or Medical Supply3Name of Associated Covered Device or Medical Supply4Name of Associated Covered Device or Medical Supply5Total Amount of Payment USDollarsDate of PaymentForm of Payment or Transfer of ValueExpenditure Category1Expenditure Category2Expenditure Category3Expenditure Category4Expenditure Category5Expenditure Category6Is Preclinical Research IndicatorIs Delay in Publication IndicatorName of StudyIs Dispute Status for PublicationRecord IDProgram YearPayment Publication DateClinicalTrials Gov IdentifierResearch Information LinkContext of Research
UNCHANGEDCovered Recipient Physician201803.0ChristopherLucasti4290 Glendale MilfordCincinnatiOH45242United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal Medicine|Infectious DiseaseNJMerck Sharp & Dohme Corporation100000000053Merck Sharp & Dohme CorporationNJUnited StatesCoveredMK-765512172013-10-17In-kind items and servicesFalseFalseA Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 & ImipenemCilastatin Versus ImipenemCilastatin Alone in Patients with CFalse28134517020132020-01-17
UNCHANGEDCovered Recipient Physician346072.0KEVINDMULLEN2500 METROHEALTH DRCLEVELANDOH44109United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal Medicine|GastroenterologyOHMerck Sharp & Dohme Corporation100000000053Merck Sharp & Dohme CorporationNJUnited StatesCoveredVICTRELIS85031402.0106062926.02092013-10-25In-kind items and servicesFalseFalseA Phase 3 Safety and Efficacy Study of BoceprevirPeginterferon Alfa 2aribavirin in Chronic HCV Genotype 1 IL28B CC Subjects Protocol No P07755 also known as MK 3034 040 00False10606292620132020-01-17
UNCHANGEDCovered Recipient Teaching Hospital140119.0433.0Rush University Medical Center1653 W. CONGRESS PARKWAYCHICAGOIL60612United States1108892.0ROHAMMOFTAKHAR3 RICHLAND MEDICAL PARK DRSUITE 310COLUMBIASC29203-6849United StatesMedical DoctorAllopathic & Osteopathic Physicians|Neurological SurgeryILSCWAWI63299.0ANDREWKELLYJOHNSON1653 W CONGRESS PKWYCHICAGOIL60612-3833United StatesMedical DoctorAllopathic & Osteopathic Physicians|Neurological SurgeryGAIL53027.0DEMETRIUSKLOPES1725 W HARRISON STSUITE 855CHICAGOIL60612-3841United StatesMedical DoctorAllopathic & Osteopathic Physicians|Neurological SurgeryIL100458.0MICHAELWCHEN201 RIDGE STSTE. 311COUNCIL BLUFFSIA51503-4643United StatesDoctor of OsteopathyAllopathic & Osteopathic Physicians|Psychiatry & Neurology|NeurologyIANESiemens Medical Solutions USA, Inc.100000010755Siemens Medical Solutions USA, Inc.PAUnited StatesCombinationAX - Angiography Fluoroscopy/Radiology379942013-10-28Cash or cash equivalentFalseFalseEval of improved IQ of c-arm images using new algorithms for MAR and cone beam artifact reduction Rush-2012-AX-01-40003-01-LopesFalse29882735420132020-01-17
UNCHANGEDCovered Recipient Teaching Hospital450076.0933.0University Of Texas M. D. Anderson Cancer Center1515 HOLCOMBE BLVDHOUSTONTX77030United States327012.0LUISFAYADMD ANDERSON CANCER CENTER1515 HOLCOMBE UNIT 429HOUSTONTX77030United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal Medicine|Hematology & OncologyTXPfizer Inc.100000000286Pfizer Inc.NYUnited StatesNon-Covered4562013-12-18Cash or cash equivalentFalseFalseAN OPENLABEL RANDOMIZED PHASE 3 STUDY OF INOTUZUMAB OZOGAMICIN ADMINISTERED IN COMBINATION WITH RITUXIMAB COMPARED TO DEFINED INVESTIGATORS CHOICE THERAPY IN SUBJECTS WITH RELAPSED OR REFRACTORY CD22POSITIVE AGGRESSIVE NONHODGKIN LYMPHOMA WHO AFalse20752850820132020-01-17
UNCHANGEDCovered Recipient Physician50226.0MAMTAKJAIN1936 AMELIA CTDALLASTX75235United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal Medicine|Infectious DiseaseTXViiV Healthcare Company100000005550ViiV Healthcare CompanyNCUnited StatesNon-CoveredTRELAVUE312013-09-20Cash or cash equivalentFalseFalseA Phase IIIb randomized openlabel study of the safety and efficacy of dolutegravirabacavirlamivudine once daily compared to atazanavir and ritonavir plus tenofoviremtricitabine once daily in HIV1 infected antiretroviral therapy naive womenFalse10620071820132020-01-17
UNCHANGEDCovered Recipient Physician201803.0CHRISTOPHERLUCASTI732 SHORE RDSOMERS POINTNJ8244United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal Medicine|Infectious DiseaseNJMerck Sharp & Dohme Corporation100000000053Merck Sharp & Dohme CorporationNJUnited StatesCoveredMK-765512172013-12-28In-kind items and servicesFalseFalseA Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 & ImipenemCilastatin Versus ImipenemCilastatin Alone in Patients with CFalse28134549620132020-01-17
UNCHANGEDCovered Recipient Physician831829.0CHRISTIANGERALDSCHROCK3366 OAKDALE AVE N STE 520MINNEAPOLISMN55422United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal Medicine|Infectious DiseaseMNMerck Sharp & Dohme Corporation100000000053Merck Sharp & Dohme CorporationNJUnited StatesCoveredMK-76551102013-12-20In-kind items and servicesFalseFalseA Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 & ImipenemCilastatin Versus ImipenemCilastatin Alone in Patients with CFalse28140271020132020-01-17
UNCHANGEDCovered Recipient Physician11323.0JASONFOERST127 Mcclanahan St SwSte 300RoanokeVA24014United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal MedicineNHMedtronic Vascular, Inc.100000010384Medtronic Vascular, Inc.MNUnited StatesNon-Covered11402013-10-24Cash or cash equivalentFalseFalseCoreValve EUSFalse10588991320132020-01-17
UNCHANGEDCovered Recipient Teaching Hospital160058.0582.0State University Of Iowa200 Hawkins DrIowa CityIA52242United States1045914.0SIFHANSDOTTIR200 HAWKINS DRIOWA CITYIA52242-1009United StatesMedical DoctorAllopathic & Osteopathic Physicians|Internal Medicine|Pulmonary DiseaseIAActelion Pharmaceuticals US, Inc.100000000253Actelion Clinical Research, Inc.NJUnited StatesCoveredOPSUMIT MACITENTAN6621550130.035752013-12-04In-kind items and servicesFalseFalseSERAPHIN OL HQ - AC-055-303False3024168220132020-01-17NCT00667823http://clinicaltrials.gov/ct2/show/NCT00667823?term=actelion+seraphin+ol&rank=1
UNCHANGEDCovered Recipient Teaching Hospital380009.01050.0Oregon Health & Science University3181 SW Sam Jackson Park RdMailcode CR96PortlandOR97239United StatesPfizer Inc.100000000286Pfizer Inc.NYUnited StatesCoveredSUTENT69055038.039202013-12-17Cash or cash equivalentTrueFalseFalse20765875920132020-01-17